FIDVAXI Trademark

Trademark Overview


On Thursday, September 1, 2022, a trademark application was filed for FIDVAXI with the United States Patent and Trademark Office. The USPTO has given the FIDVAXI trademark a serial number of 79352877. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Genexine, Inc.. The FIDVAXI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors
fidvaxi

General Information


Serial Number79352877
Word MarkFIDVAXI
Filing DateThursday, September 1, 2022
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7227043
Registration DateTuesday, November 28, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenexine, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameGenexine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameGenexine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 4, 2024FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 4, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 28, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 12, 2023NOTIFICATION PROCESSED BY IB
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 23, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 13, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 13, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 2, 2023REFUSAL PROCESSED BY IB
Thursday, January 12, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 12, 2023REFUSAL PROCESSED BY MPU
Thursday, November 3, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 2, 2022ASSIGNED TO EXAMINER
Tuesday, October 25, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 20, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB